QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
 |
BRISBANE, Australia, June 25, 2025 /PRNewswire/ --
More Articles ...
- Automation Anywhere Collaborates with Akshaya Patra to Power its Mission of Providing 5 million Daily Meals with Smarter AI Logistics
- BANNER S C (TULLIMBAR) PTY LTD ANNOUNCES OFFERING OF AUD 5,649,878 SENIOR SECURED LOAN NOTE OFFER
- Blue Whale Energy partners UNIGRID to deploy urban C I Battery storage across Southeast Asia
- UOB Asset Management anticipates a greater focus on Asian markets in 3Q 2025
- Dstny Group appoints Pieter Verstraeten as Chief Revenue Officer to accelerate sustainable growth
Health & Wellness
What to Look for When Choosing a Dental Clinic Melbourne Patients Can Rely On
Hashtag.net.au
Look at the Range of Dental Care Available Choosing a dental practice is easier when patients can access different types of care in one place. A dental clinic Melbourne patients visit may provide gen...
What Do Clinical Teams Need from Their Surgical Supply Partners?
Hashtag.net.au
In clinical settings, surgical supply partners aren’t just vendors. They sit quietly behind the scenes of operating lists, specialist consultations, treatment rooms and recovery workflows. When they...
The Growing Focus on Communication Development in Children
Hashtag.net.au
The early developmental years of a child's life represent a critical window for neurological growth, behavioural shaping, and language acquisition. During this formative phase, the ability to interpre...